SG11201806907XA - Obesity risk diagnosis kit and method for analyzing risk of obesity onset - Google Patents
Obesity risk diagnosis kit and method for analyzing risk of obesity onsetInfo
- Publication number
- SG11201806907XA SG11201806907XA SG11201806907XA SG11201806907XA SG11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA
- Authority
- SG
- Singapore
- Prior art keywords
- obesity
- risk
- analyzing
- onset
- diagnosis kit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016051038 | 2016-03-15 | ||
PCT/JP2017/009903 WO2017159592A1 (ja) | 2016-03-15 | 2017-03-13 | 肥満リスクの診断キット,及び肥満の発症リスクの分析方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201806907XA true SG11201806907XA (en) | 2018-09-27 |
Family
ID=59851484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201806907XA SG11201806907XA (en) | 2016-03-15 | 2017-03-13 | Obesity risk diagnosis kit and method for analyzing risk of obesity onset |
Country Status (8)
Country | Link |
---|---|
US (1) | US20190078074A1 (zh) |
EP (1) | EP3431594A1 (zh) |
JP (1) | JPWO2017159592A1 (zh) |
CN (1) | CN108779454A (zh) |
AU (1) | AU2017234903A1 (zh) |
CA (1) | CA3014526A1 (zh) |
SG (1) | SG11201806907XA (zh) |
WO (1) | WO2017159592A1 (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1666607A4 (en) * | 2003-07-31 | 2007-11-21 | Banyu Pharma Co Ltd | METHOD OF EVALUATING AN EFFECTIVE COMPOUND FOR TREATING OBESITY USING SLC25A10 |
JP5804599B2 (ja) * | 2009-05-13 | 2015-11-04 | 国立研究開発法人理化学研究所 | 内臓脂肪型肥満の検査薬およびその利用 |
US20130143748A1 (en) * | 2010-05-27 | 2013-06-06 | Sekisui Medical Co., Ltd. | Methods for detection of risk of obesity and risk of onset of diabetes |
JP6230546B2 (ja) * | 2012-12-26 | 2017-11-15 | 中島 利博 | 肥満症の予防及び治療作用を有する化合物のスクリーニング方法 |
-
2017
- 2017-03-13 CN CN201780017278.1A patent/CN108779454A/zh active Pending
- 2017-03-13 US US16/084,969 patent/US20190078074A1/en not_active Abandoned
- 2017-03-13 EP EP17766592.4A patent/EP3431594A1/en not_active Withdrawn
- 2017-03-13 WO PCT/JP2017/009903 patent/WO2017159592A1/ja active Application Filing
- 2017-03-13 SG SG11201806907XA patent/SG11201806907XA/en unknown
- 2017-03-13 JP JP2018505907A patent/JPWO2017159592A1/ja active Pending
- 2017-03-13 CA CA3014526A patent/CA3014526A1/en not_active Abandoned
- 2017-03-13 AU AU2017234903A patent/AU2017234903A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN108779454A (zh) | 2018-11-09 |
CA3014526A1 (en) | 2017-09-21 |
WO2017159592A1 (ja) | 2017-09-21 |
US20190078074A1 (en) | 2019-03-14 |
EP3431594A1 (en) | 2019-01-23 |
AU2017234903A1 (en) | 2018-08-30 |
JPWO2017159592A1 (ja) | 2019-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015016047A (es) | Metodo y sistema para mantener o mejorar el bienestar. | |
ATE554389T1 (de) | Apex als marker für lungenkrebs | |
GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
EP3816303A3 (en) | Breast cancer detection kit or device, and method for detecting breast cancer | |
NZ607282A (en) | Method for using gene expression to determine prognosis of prostate cancer | |
EP3800253A3 (en) | Prostate cancer detection kit or device, and detection method | |
EP4219765A3 (en) | Prostate cancer prognosis using biomarkers | |
WO2014140933A8 (en) | Method for the prognosis and treatment of cancer metastasis | |
MX2016003368A (es) | Tecnicas de analisis de imagenes para diagnosis de enfermedades. | |
SG11201811263WA (en) | Molecular marker, reference gene, and application and test kit thereof, and method for constructing testing model | |
HK1115636A1 (en) | Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1 | |
WO2018007872A9 (en) | Biomarkers for inflammatory bowel disease | |
WO2015131151A3 (en) | Method and apparatus for determining markers of health by analysis of blood | |
MX2021012347A (es) | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. | |
WO2015034886A3 (en) | Wellness panel for companion animals | |
MX2018001697A (es) | Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores. | |
EA201490946A1 (ru) | Способ количественной оценки лечения рака | |
EP2977467A3 (en) | Method, use of marker, and determination device for obtaining information on plural types of cancers | |
MX2017014196A (es) | Deteccion de factores de virulencia microbiana bucal. | |
EP3495502A3 (en) | Biomarkers for premature birth | |
WO2009149319A3 (en) | Gene expression profiles associated with asthma exacerbation attacks | |
BR112016028838A2 (pt) | anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer | |
MX359376B (es) | Metodo y kit para la determinacion de cobre libre en suero. | |
MX2016012278A (es) | Deteccion temprana de preeclampsia. | |
ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs |